Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:

Not Applicable

Active, not recruiting

Conditions: Rheumatoid Arthritis
Cardiovascular Diseases
Hyperlipidemias

Interventions: Behavioral: Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
Behavioral: Standard of care

First Posted Date: 2020-07-28

Last Posted Date: 2024-07-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 79

Registration Number: NCT04488497

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Narrative Medicine and Pediatric Oncology

Not Applicable

Completed

Conditions: Pediatric Residents Rotating in Pediatric Oncology

Interventions: Other: Narrative medicine curriculum

First Posted Date: 2020-07-28

Last Posted Date: 2021-09-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 66

Registration Number: NCT04489316

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Social Reward and Its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Symptom Review and Psychoeducation (SRP)
Behavioral: "Engage & Connect" Psychotherapy

First Posted Date: 2020-07-27

Last Posted Date: 2024-11-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 60

Registration Number: NCT04487730

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Cognitive Training in Stroke Rehabilitation

Not Applicable

Recruiting

Conditions: Cognitive Impairment
Executive Dysfunction

Interventions: Behavioral: ASCEND-I

First Posted Date: 2020-07-15

Last Posted Date: 2024-02-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 70

Registration Number: NCT04472351

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

The Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail Injection

Phase 4

Withdrawn

Conditions: Nail Diseases

Interventions: Device: External thermomechanical device delivering cold and vibration stimuli
Drug: Ethyl chloride skin refrigerant spray
Device: External thermomechanical device without delivering cold and vibration stimuli

First Posted Date: 2020-06-09

Last Posted Date: 2023-04-07

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04422795

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: 5 days Radiation Therapy (32.5 Gy in 5 fractions)
Radiation: 20 days Radiation therapy (55 Gy in 20 fractions)

First Posted Date: 2020-06-09

Last Posted Date: 2024-05-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 134

Registration Number: NCT04422132

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)

Phase 4

Terminated

Conditions: COVID-19

Interventions: Drug: Enoxaparin sodium
Drug: Unfractionated heparin
Drug: Fondapariniux
Drug: Argatroban

First Posted Date: 2020-05-28

Last Posted Date: 2023-09-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 14

Registration Number: NCT04406389

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States

Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC
Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2020-05-26

Last Posted Date: 2024-03-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT04402151

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

Phase 2

Active, not recruiting

Conditions: Hematologic Malignancy
Bone Marrow Transplant

Interventions: Drug: Tocilizumab
Drug: Fludarabine
Drug: Melphalan
Drug: Anti-thymocyte globulin (rabbit)
Radiation: Total Body Irradiation

First Posted Date: 2020-05-20

Last Posted Date: 2024-08-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 21

Registration Number: NCT04395222

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy

Not Applicable

Terminated

Conditions: Prostate Cancer
Quality of Life

Interventions: Procedure: Retzius sparing

First Posted Date: 2020-05-19

Last Posted Date: 2022-03-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 3

Registration Number: NCT04393831

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy